Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-054455

Chief Executive Officer sold 7,800 shares at an average $40.22 ($313,753)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ciechanover Isaac E. Chief Executive Officer 2018-10-04 Sale −2,600 $40.09 $104,234 56,078 I
Ciechanover Isaac E. Chief Executive Officer 2018-10-04 Sale −1,300 $41.34 $53,742 54,778 I
Ciechanover Isaac E. Chief Executive Officer 2018-10-05 Sale −1,900 $39.58 $75,202 52,878 I
Ciechanover Isaac E. Chief Executive Officer 2018-10-05 Sale −1,900 $40.25 $76,475 50,978 I
Ciechanover Isaac E. Chief Executive Officer 2018-10-05 Sale −100 $41.00 $4,100 50,878 I
Open-market sales · 7,800 sh · avg $40.22 · $313,753
Loading xslF345X03/doc4.xml…